Greetings! Please Share & Subcribe.
Women with silicone and saline gel-filled breast implants may slightly increase the risk of developing a rare immune-system cancer near their implants, said media reports quoting U.S. Food and Drug Administration (FDA) Thursday.
The FDA has received nearly 60 reports since 1997 of anaplastic large cell lymphoma (ALCL) from women who had breast implants.
ALCL, a rare and aggressive blood cancer generally formed around the shell of the implant, makes up only about 3 percent of all blood cancers in adults, said the Lymphoma Research Foundation.
The FDA however said the number is tough to verify and some reports could be duplicates.
Overall the agency still considers implants safe, saying women without symptoms should not change their routine monitoring.
"We need more data" to better understand the issue, “ said Dr. William Maisel, chief scientist in the FDA's device unit.
An estimated 5 million to 10 million women around the world have breast implants.
Silicone implants were banned for most U.S. women in 1992 after some complained the devices leaked and made them chronically ill. But widespread sales resumed in 2006 with FDA approval over vocal protests from consumer advocates.
XINHUA
0 Comments